You’d give up almost anything for a chance to beat your cancer. And many treatments will test your resolve to do just that. Hair loss is one of the sacrifices most-often associated with chemo and radiation. Here’s what you can expect.
Oligometastatic lung cancer is cancer that has spread from the primary location to one or a few other organs. In most cases, oligometastatic lung disease occurs in the brain. Synchronous oligomestatases can occur during the initial diagnosis, while metachronousoligometastases are seen within six months of diagnosis. The oligometastatic phenotype is typically a function of the current biology of cancer in the body.
In several clinical trials to manage oligometastatic lung cancer:
Oligometastatic non-small cell lung cancer patients who received locally ablative therapy after systematic therapy showed improvement in their progression-free survival and overall survival.
It was noted that most of the patients who benefited from this trial were those with 0 to 1 metastatic lesion.
In a screening study, patients with up to 5 metastatic foci in different types of cancers were given definitive treatment and standardized palliative therapy with stereotactic radiotherapy. Improvement in progression-free survival and overall survival was observed in this group as well. A randomized clinical trial is underway to confirm these results.
Another trial was conducted to assess the outcomes in patients with oligometastatic lung cancer when immunotherapy is added to locally ablative therapy. The patients were given pembrolizumab (Keytruda) for six months with excellent results.
These few trials and many others have confirmed that locally ablative therapy can be used as a treatment option for oligometastatic lung disease. As for immunotherapy, efforts are ongoing to help identify its biomarkers to help direct oncologists on the right patients who can receive the combination with definitive results.
Currently, randomized trials are being carried out to evaluate the efficacy of locally ablative therapy in treating oligometastatic lung cancer. Also, the role of immunotherapy has to be confirmed in such a setting to help improve outcomes for patients. Clinicians now have an essential job of identifying which patients can benefit from this therapy.
You Might Also Enjoy...
You’d give up almost anything for a chance to beat your cancer. And many treatments will test your resolve to do just that. Hair loss is one of the sacrifices most-often associated with chemo and radiation. Here’s what you can expect.
Three oncology practices with a combined total of ten physicians have recently joined The Center for Cancer and Blood Disorders (The Center), the growing North Texas independent oncology practice, an affiliate of OneOncology, announced today.
Most people are familiar with radiation and chemotherapy as effective go-to treatments, but there are many more cancer-fighting weapons in our arsenal. Here’s how hormone therapy may be a key player in your cancer treatment plan.
Pain isn’t a guaranteed side effect of cancer, but it can be part of the experience for some. Many hesitate to discuss cancer pain, but controlling it is important for your overall well-being. Discuss your pain symptoms with your treatment team.
Colon cancer can be life-threatening, but you may be able to sidestep this aggressive disease by taking a few precautionary steps. If you’re in a high-risk group, learn how to gain the upper hand and increase your chances of preventing colon cancer.
When you catch a cold, your immune system attacks the virus that caused it. But when you have cancer, it’s not so easy. Find out how your immune system can benefit from immunotherapy and kick cancer to the curb.